Virtual Village for Young Parents (NCT07226401) | Clinical Trial Compass
RecruitingNot Applicable
Virtual Village for Young Parents
United States80 participantsStarted 2025-11-11
Plain-language summary
This project will study virtual delivery of Safe Dates for Young Parents (SDYP), a 10-session, group-based intimate partner violence (IPV) prevention program tailored for adolescents and young adults who are pregnant or parenting. This program has the potential to improve the health and well-being of young parents and their children, and virtual delivery may improve participants' ability to attend. The main questions it aims to answer are: (1) Is it feasible and acceptable to implement SDYP in a virtual setting? (2) Are SDYP participants less likely to experience IPV than participants in an alternate health education program? Participants will be invited to a series of virtual program sessions for either SDYP or a health education program focused on physical activity and nutrition and will be asked to complete surveys before the programs begin and up to 6 months later.
Who can participate
Age range
16 Years – 21 Years
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
Pregnant or parenting youth (Pilot RCT participants)
* Aged 16-21 years.
* Currently pregnant, partner of a pregnant person, or parenting a child (i.e., have contact with child at least once per week).
* Able to speak and read English.
* Willing and able to provide written informed consent.
* Willing and able to provide adequate contact/locator information.
Facilitators (IDI participants)
* Aged 18 years or older.
* Trained and served as a facilitator of the virtual SDYP intervention.
* Able to speak and read English.
* Able and willing to provide verbal informed consent.
Exclusion Criteria (Pilot RCT participants):
* Has any other condition that, in the opinion of the PI or their designee, would preclude informed consent, make study participation unsafe, complicate interpretation of study outcome data, or otherwise interfere with achieving the study objectives.
* Currently participating or will be participating in a violence prevention education program in the next 3 months.
* Previously participated in the Empowering Young Parents study.
Questions worth asking your doctor
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
Questions for the trial coordinator
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
What they're measuring
1
Participant attendance
Timeframe: From the first to the last session of SDYP (typically 10 weeks)
2
Participant engagement
Timeframe: From the first to the last session of SDYP (typically 10 weeks)
3
Program adherence
Timeframe: From the first to the last session of SDYP (typically 10 weeks)
4
Physical IPV perpetration
Timeframe: Past 3 months measured at baseline and 3 to 6 months after baseline
5
Physical IPV victimization
Timeframe: Past 3 months measured at baseline and 3 to 6 months after baseline
6
Psychological IPV perpetration
Timeframe: Past 3 months measured at baseline and 3 to 6 months after baseline
7
Psychological IPV victimization
Timeframe: Past 3 months measured at baseline and 3 to 6 months after baseline